Parilman & Associates

Actos class action lawsuits and recalls have already been filed in the France, who suggests taking the drug off the United States market. Most recently, December 21, Canada filed a class action lawsuit against the Takeda Pharmacuetical Company and Eli Lilly, who failed to properly research and warn consumers about the high risk of bladder cancer.

Many Nursing Home complaints have been filed across the U.S. concerning negligent care and abuse.  In 2010, a resident in a Michigan nursing home choked to death on her own tracheostomy tube. The nursing home is being sued by the family of Alicia Cegers against the Borgess Gardens nursing home in Kalamazoo.  

Recently fourteen hospitals in California have been fined for serious medical negligence. Seven of the fourteen hospitals were fined for leaving surgical tools inside of the patients’ bodies. Other mistakes include improper administration of medicines, and serious birth injuries, including Cerebral Palsy, due to negligence during delivery.

Federal Health experts met Thursday, December 8, 2011, to discuss the warning labels administered by Bayer's drug Yaz. A close vote, 15-11 experts agree that the benefits of birth control pills containing drospirenone not outweigh the risks, especially when there are alternative birth control pills out there with the same benefits and not the risks. However, the FDA experts voted 21-5 that Bayer should update their warning labels, based on the evidence in recent studies, which suggest increased risk of blood clots.

There have been a vast number of medical complications experienced by women in the U.S.who have received a transvaginal mesh implant for repair of pelvic organ prolapse.

December 8, 2011 the FDA advisory committee is scheduled to review the safety of Yaz ans Yasmin birth control pills. Just days before this meeting, the FDA released a safety report suggesting that Yasmin and Yaz labels should include a warning for increased risk of blood clots.

Yaz and Yasmin has been confirmed through numerous studies in the U.S and Canada to increase the risk of blood clots. The birth control pill, sold by Bayer pharmaceuticals, may increase the risk of blood clots up to three times over some other birth control pills.

Raptiva withdrawn due to causing serious injury including PML to patients who use it

Pharmaceutical company Genentech Inc. is recalling the defective drug Raptiva, which is used to treat psoriasis because of the drug's links to a fatal brain infection, according to a news report in the San Francisco Chronicle. This voluntary drug recall from San Francisco-based Genentech comes six months after the U.S. Food and Drug Administration (FDA) approved updated labeling for the drug to warn consumers about Raptiva's links to a rare nervous system disorder called progressive multifocal leukoencephalopathy or PML. So far, there are three known confirmed fatal cases of PML in patients taking Raptiva. One other patient who was taking the drug developed similar neurological symptoms and died of an unknown cause, FDA officials said.

New U.S. Food and Drug Administration (FDA) regulations imposed upon the controversial diabetes drug Avandia will prohibit local retail pharmacies to carry the medication due to a confirmed risk for heart attack and other cardiovascular complications.

This motion applies to three anti-diabetes drugs manufactured by GlaxoSmithKline, Avandia, Avandamet and Avandaryl, that contain rosiglitazone - a drug that increases sensitivity to insulin and removes extra glucose from blood.

A new study titled “Bisphosphonate Use and Atypical Fractures of the Femoral Shaft” published in the May 2011 issue of the New England Journal of Medicines further strengthens the claim that bisphosphonates, like Fosamax, may increase the risk of atypical thigh bone breaks. This is the 4^th study from the publication which favorably promotes the mounting litigation against the drug’s manufacturer Merck for allegedly producing a defective and harmful drug, ultimately providing Parilman Fosamax Femur Fracture lawyers with more fuel to obtain justice for patients harmed by defective drugs.